Abstract
It is known that the causative diseases of secondary #hypertrophic pachymeningitis (HP) include infections, malignant tumors, autoimmune
diseases. Although myelodysplastic syndromes (MDS) are often accompanied
by certain autoimmune diseases, secondary HP with MDS is rare. We here
describe the patient with HP complicated by MDS and have severe
resistance to the steroid therapy and successfully treated with the
combination of #corticosteroids and 5-Azacytidine (5-Aza). Administration
of 5-Aza might be a useful therapeutic option for patients with
refractory autoimmune diseases complicated with MDS.Hypertrophic pachymeningitis (HP) are secondarily caused by various
diseases such as infections, malignant tumors, and autoimmune diseases
[1]. Myelodysplastic syndromes (MDS) are #hematopoietic malignancies
characterized by pancytopenia in the peripheral blood and is often
complicated by autoimmune diseases [2-4]. However, there are few reports
of MDS complicated by HP 5-Azacytidine (5-Aza) is the first-line
treatment options for high-risk MDS patients, for whom #allogeneic
hematopoietic transplantation is not eligible due to the old age and/or
comorbidities. Here we report the first case of MDS complicated by HP,
which was successfully treated with the combination of 5-Aza and
corticosteroids.
For more articles on BJSTR Journal please click on https://biomedres.us/
For more Medical Casereports Articles on BJSTR
Successful Treatment of Hypertrophic Pachymeningitis Complicated with Myelodysplastic Syndromes with 5-Azacytidine by Chisato Ashida in BJSTR
Follow on Twitter : https://twitter.com/Biomedres01
Follow on Tumbler: https://biomedres.tumblr.com/
Like Our Pins On : https://www.pinterest.com/biomedres/
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.